Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - pancreas powder - capsule, coated pellets - 150mg - pancreas powder 150mg

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - pancreatin -

Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - abbott hbv sequencing is an in vitro assay for determining the dna sequence of the reverse transcriptase (rt) region of the polymerase (pol) gene of hepatitis b virus (hbv). the test is intended for use as an aid in the management of patients with chronic hbv. the abbott hbv sequencing assay is not intended for use in the screening of blood, plasma, or tissue donors for hbv, or to be used as a diagnostic test to confirm the presence of hbv infection.

Den europeiske union - fransk - EMA (European Medicines Agency)

abbott laboratories ltd. - adalimumab - spondylitis, ankylosing; arthritis, rheumatoid; arthritis, psoriatic; crohn disease - immunosuppresseurs - rhumatoïde arthritistrudexa en association avec le méthotrexate, est indiqué pour:le traitement de la forme modérée à grave, la polyarthrite rhumatoïde active chez l'adulte lorsque la réponse à la maladie-antirhumatismaux médicaments, y compris le méthotrexate a été insuffisante. le traitement de sévère, active et progressive de la polyarthrite rhumatoïde chez les adultes non précédemment traités par le méthotrexate. trudexa peut être administré en monothérapie en cas d'intolérance au méthotrexate ou lorsque la poursuite du traitement avec le méthotrexate est inapproprié. trudexa a été montré pour réduire le taux de progression des lésions articulaires mesurés par radiographie et pour améliorer la fonction physique, lorsqu'il est administré en association avec le méthotrexate. psoriasique arthritistrudexa est indiqué pour le traitement des actifs et progressive de l'arthrite psoriasique chez l'adulte lorsque la réponse à la précédente disease-modifying anti-rheumatic drug therapy a été insuffisante. ankylosante spondylitistrudexa est indiqué pour le traitement des adultes atteints de graves actif de la spondylarthrite ankylosante qui ont eu une réponse inadéquate au traitement conventionnel. la maladie de crohn diseasetrudexa est indiqué pour le traitement de sévère, active la maladie de crohn, chez les patients qui n'ont pas répondu malgré une pleine et adéquate cours du traitement avec un corticostéroïde et/ou un immunosuppresseur; ou qui sont intolérants ou d'avoir de contre-indications médicales pour ces thérapies. pour le traitement d'induction, trudexa doit être administré en association avec cortiocosteroids. trudexa peut être administré en monothérapie en cas d'intolérance aux corticoïdes ou lorsque la poursuite du traitement avec des corticostéroïdes n'est pas appropriée (voir la section 4.

Den europeiske union - engelsk - EMA (European Medicines Agency)

abbott laboratories ltd. - adalimumab - spondylitis, ankylosing; arthritis, rheumatoid; arthritis, psoriatic; crohn disease - immunosuppressants - rheumatoid arthritistrudexa in combination with methotrexate, is indicated for:the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.trudexa can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.trudexa has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.psoriatic arthritistrudexa is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.ankylosing spondylitistrudexa is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.crohn's diseasetrudexa is indicated for treatment of severe, active crohn's disease, in patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies. for induction treatment, trudexa should be given in combination with cortiocosteroids. trudexa can be given as monotherapy in case of intolerance to corticosteroids or when continued treatment with corticosteroids is inappropriate (see section 4.2).

Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr hbcore assay is an in vitro chemiluminescent immunoassay (chlia) for the qualitative detection of total antibody to hepatitis b core antigen (anti-hbc) in human serum and plasma. it is intended to be used as a screen for blood and plasma to prevent transmission of hepatitis b virus (hbv) to recipients of blood and blood components and as an aid in the diagnosis of hbv infection. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating. use with abbott prism system.

Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr hbsag assay is an in vitro chemiluminescentimmunoassay (chlia) for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum or plasma. it is intended as a screen for donated blood to prevent transmission of hepatitis b virus (hbv) to recipients of blood and blood components and as an aid in the diagnosis of ongoing or previous hepatitis b viral infection. use with abbott prism system. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating.

Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr htlv-i/htlv-ii assay is an in vitro chemiluminescent immunoassay (chlia) for the qualitative detection of antibodies to human t-lymphotropic virus type i and/or human t-lymphotropic virus type ii (anti-htlv-i/htlv-ii) in human serum or plasma. the abbott prism htlv-i/htlv-ii (chlia) is intended as a screen for donated blood to prevent transmission of htlv-i and htlv-ii to recipients of blood and blood components and as an aid in the diagnosis of htlv-i and htlv-ii infections. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating. use with abbott prism system.

Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the abbott realtime cmv assay is an in vitro polymerase chain reaction (pcr) assay for the quantification of cytomegalovirus (cmv) dna in human plasma or whole blood. the assay is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of initiation of therapy and for use as an aid in monitoring viral response to antiviral treatment as measured by changes in plasma or whole blood dna levels. this assay is not intended to be used as a screening for cmv or as a diagnostic test to confirm the presence of cmv infection.

Singapore - engelsk - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the abbott realtime ct/ng assay is an in vitro polymerase chain reaction (pcr) assay for the direct, qualitative detection of the plasmid dna for c. trachomatis and the genomic dna of n. gonorrhoeae in female endocervical or vaginal swab specimens, male urethral swab specimens, or in male and female urine specimens.